Schedule 13G ownership disclosure

CYTOSORBENTS CORP

Common Stock · CUSIP: 23283X206

Event date: 2024-12-31

Filing-level shares
3,899,102
Percent of class
7.13%
  • The Vanguard Group

    Shares: 3,899,102 · Class: 7.13%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000334
Form type
SCHEDULE 13G
Filer
Cytosorbents Corp
CIK
CIK 1175151
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub